Literature DB >> 1915444

Expression of MHC class I and II antigens and the Il-2 receptor in rejection, myocarditis and dilated cardiomyopathy.

G Hufnagel1, B Maisch.   

Abstract

In myocarditis and dilated cardiomyopathy a secondary immunopathogenesis is likely, since alterations to the humoral and cellular immune system have been repeatedly demonstrated. In rejection after heart transplantation activation of the immune system has been clearly seen. This may be comparable to myocarditis and thus could be a model for inflammatory heart disease. This study was set up to investigate whether an increased expression of antigens of the major histocompatibility complex and of the Il2 receptor in endomyocardial biopsies of patients after cardiac transplantation, myocarditis and dilated cardiomyopathy takes place. Cryostat sections were investigated immunohistologically by the immunoperoxidase test. There was an expression of class II antigens (HLA-DR, HLA-DP, HLA-DQ) in acute rejection and in myocarditis and in some patients with dilated cardiomyopathy on endothelial cells, interstitial cells but not on the myocytes. The results for class I (HLA-A, B, C) are similar, but in addition an expression on myocytes was observed in myocarditis and rejection. A second immunopathogenesis is most likely in some patients with dilated cardiomyopathy. The expression of the Il2 receptor on interstitial cells as a specific marker of cell activation was only seen in acute rejection and in some cases of myocarditis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915444     DOI: 10.1093/eurheartj/12.suppl_d.137

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

Review 1.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 2.  Scintigraphic detection of inflammatory heart disease.

Authors:  A J Morguet; D L Munz; H Kreuzer; D Emrich
Journal:  Eur J Nucl Med       Date:  1994-07

3.  Vaccine strategies to prevent rheumatic fever.

Authors:  E R Brandt; M F Good
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis.

Authors:  S A Huber; A Moraska; M Choate
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  Recombinant interleukin-2 acts like a class I antiarrhythmic drug on human cardiac sodium channels.

Authors:  T Proebstle; M Mitrovics; M Schneider; V Hombach; R Rüdel
Journal:  Pflugers Arch       Date:  1995-02       Impact factor: 3.657

Review 6.  Infectious myocarditis: the role of the cardiac vasculature.

Authors:  Linde Woudstra; Lynda J M Juffermans; Albert C van Rossum; Hans W M Niessen; Paul A J Krijnen
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

7.  Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart Muscle.

Authors:  Michael Didié; Satish Galla; Vijayakumar Muppala; Ralf Dressel; Wolfram-Hubertus Zimmermann
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

8.  Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells.

Authors:  Suresh Pallikkuth; Rajendra Pahwa; Bagavathi Kausalya; Shanmugam Saravanan; Li Pan; R Vignesh; Syed Iqbal; Sunil S Solomon; Kailapuri G Murugavel; Selvamuthu Poongulali; Nagalingeswaran Kumarasamy; Savita Pahwa
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.